Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotide.

  title={Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotide.},
  author={Niki Karavitaki and Helen E. Turner and Christopher B T Adams and Simon A. Cudlip and James V. Byrne and Violet Fazal-Sanderson and S Rowlers and Peter Trainer and John A.H. Wass},
  journal={Clinical endocrinology},
  volume={68 6},
BACKGROUND Macroadenomas causing acromegaly are cured surgically in only around 50% of patients. Primary medical treatment with somatostatin analogues has been suggested to be a means of treating patients with a potentially poor surgical outcome. Previous retrospective studies have also suggested that surgical debulking of pituitary tumours causing acromegaly improves control by somatostatin analogues. No prospective study using lanreotide has been carried out thus far to assess whether this is… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS


Publications citing this paper.
Showing 1-10 of 46 extracted citations

OASIS study : Therapeutic management of acromegaly in tandard clinical practice . Assessment of the efficacy of various reatment strategies

anuel Luque-Ramíreza, Ágata Carreñob, Cristina Álvarez Escolác, Carmen Fajardo Montañanaf, ontserrat Gilabertg

Similar Papers

Loading similar papers…